cl-197
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 16, 2022 (NCT05944848)
Timeline
Indications
Studied for
Mechanism of action
- Reverse transcriptaseINHIBITOR
Reverse transcriptase inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07308782 | Phase 2 | Nov 29, 2025 | Government of China |
| NCT05944848 | Phase 1 | Nov 16, 2022 | HeNan Sincere Biotech Co., Ltd, Innovaderm |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of China | Government | 1 | 1 | 1 | 2025 |
| HeNan Sincere Biotech Co., Ltd | For profit | 1 | 1 | 1 | 2022 |
| Innovaderm | For profit | 1 | 0 | 1 | 2022 |
3 organizations
Page 1 / 1